iShares Biotechnology ETF (NASDAQ:IBB) is Gray Foundation’s 4th Largest Position

Gray Foundation grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 25.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 164,872 shares of the financial services provider’s stock after purchasing an additional 33,179 shares during the quarter. iShares Biotechnology ETF accounts for about 6.2% of Gray Foundation’s holdings, making the stock its 4th biggest holding. Gray Foundation owned about 0.35% of iShares Biotechnology ETF worth $21,798,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in IBB. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth approximately $29,000. Highline Wealth Partners LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth approximately $30,000. HHM Wealth Advisors LLC lifted its stake in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $138.74 on Tuesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The company’s 50 day moving average is $135.64 and its two-hundred day moving average is $140.77.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.